MDC medlab clinical limited

Ann: Australian Patent Granted for NanoCelle Delivery Platform, page-2

  1. 4,445 Posts.
    lightbulb Created with Sketch. 337
    Many years in the waiting for official patent and here it is. This should add value to the company MC but i doubt it will. If successful phase2 nanabis cant add value (decreased value by -50%). Sp may rise a few cents but will fall back after a few days. Also since phase2 nanabis resulted in a significant decrease in company value then i feel phase2 nrgbiotic (when released) will only offer a short term increase by about 5c before falling back. Great advancements in company strength but zero value added.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.